johnson & johnson news - Search News

Johnson & Johnson Q4 Profit Decreases

Hosted on MSN · 1h

Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the look-back and look-ahead on an earnings call,

Barron's on MSN · 2h

Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth

Johnson & Johnson unveiled financial results that beat Wall Street expectations as the company braces for one of its top-selling medicines, Stelara, to go off patent in the coming weeks.Fourth-quarter sales,

Business Insider · 5h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

Bears Hire Ben Johnson

USA Today · 1d

Detroit Lions fans crush Ben Johnson for leaving to Chicago Bears: 'Benedict Johnson'

Some Detroit Lions fans are beside themselves that Ben Johnson is staying in the NFC North with the Chicago Bears: 'Benedict Johnson'

The Washington Post · 1d

Ben Johnson agrees to become Bears head coach

Detroit Lions offensive coordinator Ben Johnson has agreed to become the Chicago Bears head coach, a person familiar with the situation told The Associated Press Ben Johnson helped Jared Goff establish himself as one of the NFL’s top quarterbacks.

Bears Wire · 3h

Ben Johnson's 3 most important hires on Bears coaching staff

Now that the head coaching search is over, the actual work begins. The roster needs improving, but it is also very important for the team to make great hires for the rest of the coaching staff. Johnson will certainly be the head decision-maker when it comes to building his group of coaches.

3h

Johnson & Johnson Tops Q4 EPS Forecasts

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

11h

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a standalone ...

5h

Johnson & Johnson reports Q4 adjusted EPS $2.04, consensus $2.02

Reports Q4 revenue $22.5B, consensus $22.45B. “2024 was a transformative year for Johnson & Johnson, marked by strong growth, an ...

Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

21hon MSN

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

4hon MSN

Johnson & Johnson posts Q4 beat as drug sales offset MedTech weakness

Johnson & Johnson (JNJ) traded flat after exceeding Street forecasts with its Q4 2024 results thanks mainly to its Innovative ...

1d

Bronstein, Gewirtz & Grossman, LLC Is Investigating Johnson & Johnson (JNJ) And Encourages Shareholders to Connect

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results